AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 52 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $63,000 | – | 15,074 | +376750.0% | 0.00% | – |
| Q3 2021 | $0 | – | 4 | -92.7% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 55 | -38.9% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 90 | -39.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 148 | +208.3% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 48 | +166.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 18 | -99.4% | 0.00% | – |
| Q3 2019 | $40,000 | +3900.0% | 3,195 | +7000.0% | 0.00% | – |
| Q2 2019 | $1,000 | -97.9% | 45 | -97.0% | 0.00% | – |
| Q1 2019 | $47,000 | -58.4% | 1,500 | -56.7% | 0.00% | – |
| Q4 2018 | $113,000 | -30.2% | 3,461 | -42.8% | 0.00% | – |
| Q2 2018 | $162,000 | – | 6,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $74,286,965 | 86.51% |
| TFG Asset Management GP Ltd | 8,000,000 | $27,840,000 | 6.94% |
| STEMPOINT CAPITAL LP | 2,662,732 | $9,266,307 | 2.72% |
| Exome Asset Management LLC | 839,472 | $2,921,362 | 2.54% |
| GREAT POINT PARTNERS LLC | 3,441,667 | $11,977,001 | 2.29% |
| Affinity Asset Advisors, LLC | 4,300,000 | $14,964,000 | 1.72% |
| Deep Track Capital, LP | 15,272,172 | $53,147,159 | 1.59% |
| Frazier Life Sciences Management, L.P. | 4,623,324 | $16,089,168 | 0.75% |
| HighVista Strategies LLC | 518,820 | $1,805,494 | 0.66% |
| Avoro Capital Advisors LLC | 12,345,678 | $42,962,959 | 0.57% |